Steven Collens
Overview
As CEO of MATTER, Steven Collens leads the premier healthcare incubator and innovation hub, which opened in February 2015. MATTER focuses on nurturing entrepreneurs and innovators developing next-generation health IT, medical devices, diagnostics, and biopharmaceutical technologies. The organization collaborates with over 200 healthcare technology ventures and partners with numerous industry-leading companies, health systems, and universities to accelerate healthcare innovation. Prior to his current role, Collens served as senior vice president at Pritzker Group, the investment firm led by Tony and J.B. Pritzker. In this capacity, he led the team that created 1871, Chicago’s center for digital startups, which became the top-ranked business incubator in the world in 2018. He also worked at Abbott Laboratories in various domestic and international functions, including product management, policy, and public affairs. Before joining Abbott, Collens was a legislative assistant to U.S. Senator Carol Moseley-Braun. Collens holds an MBA from Northwestern University’s Kellogg School of Management and a BA from Washington University in St. Louis. He serves on the boards of 1871, Hubbard Street Dance Chicago, and the Chicago High School for the Arts. He is also a member of ChicagoNEXT, the Chicago mayor’s council on technology and innovation, a Leadership Greater Chicago fellow, and a member of the Economic Club of Chicago and the Commercial Club of Chicago.
Investment Focus
- Innovative healthcare solutions
- Scalable business models
- Experienced founding teams
- Potential for significant market impact
Portfolio Companies
Reach Steven Collens directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Steven Collens
What sectors does Steven Collens invest in?
Steven Collens invests in Healthcare, Medical Devices, Diagnostics, Biotechnology and Biopharmaceuticals, and is based in Illinois, United States. Steven Collens is listed as a angel investor in the ConnectSafely investor database.
What stage does Steven Collens invest at?
Steven Collens backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 500K - 10M.
Which regions does Steven Collens invest in?
Steven Collens invests across United States.
What companies has Steven Collens invested in?
Steven Collens's portfolio includes Regroup Therapy, Sparrow Pharmaceuticals, Coeus Health, ProVazo, TeleHealth Robotics, ALTATHERA Pharmaceuticals, Qualia Health and Caretree.
Last updated · Source: ConnectSafely investor database
